论文部分内容阅读
异位妊娠是妇产科常见的急腹症之一,发病率约为1%,并有逐年增加的趋势,也是孕产妇死亡的主要原因之一,故一直视为具有高度危险的妊娠早期并发症[1]。但近几年来随着阴道B超,血β-HCG检测技术的提高,以及妇产科医生对异位妊娠警惕性的提高,早期诊断出异位妊娠并不困难,从而为未破裂前异位妊娠药物治疗创造了条件。现将我院使用甲氨蝶呤(MTX)联合米非司酮治疗异位妊娠的情况报道如下:
Ectopic pregnancy is one of the common acute abdomen obstetrics and gynecology, the incidence rate of about 1%, and there is a trend of increasing year by year, but also one of the major causes of maternal death, it has always been considered as a high risk of early pregnancy complicated by Disease [1]. However, in recent years, with the improvement of vaginal B-ultrasound and blood β-HCG detection technology and the increasing vigilance of gynecologists on ectopic pregnancy, early diagnosis of ectopic pregnancy is not difficult, Pregnancy medication to create the conditions. The hospital now using methotrexate (MTX) combined with mifepristone treatment of ectopic pregnancy are reported as follows: